Home » Newsletters » BioWorld Science

BioWorld Science

July 28, 2010

View Archived Issues

Scientists identify LEDGINs inhibiting LEDGF-integrase interaction and HIV replication

Cerenis and Novasep receive French government funds to develop CER-001

Preclinical data presented on new vaccines against tick-borne encephalitis

In vivo data support benefit of AM-966 for treatment of lung fibrosis

IRX-1 gene methylation in plasma is a potential biomarker of gastric cancer

VRS-859 improves glycemic control in preclinical studies

Cynapsus acquires license option for Adagio's PD therapeutic APL-130277

Dynavax completes first immunizations in universal flu vaccine trial

SurModics and EGEN continue siRNA delivery collaboration

Genzyme updates progress of second quarter 2010

Merck KGaA claims new Src kinase inhibitors

New Met kinase inhibitors disclosed by Merck KGaA

Antares reports phase III data on Anturol gel for overactive bladder

Boehringer Ingelheim presents new 5-HT2B receptor antagonists

Bayer Schering Pharma identifies new sGC activators

Bayer Schering Pharma discovers new HNE inhibitors

Enrollment begins in phase IIb OMS-302 trial in subjects undergoing cataract surgery

FDA grants priority review status to cladribine tablets NDA for multiple sclerosis

Sativex approved in Spain as add-on therapy for multiple sclerosis spasticity

Covidien completes tender offer for all outstanding Somanetics shares

Astellas extends license of Regeneron's VelocImmune technology

AbD Serotec licenses PTH-targeting diagnostic antibody from UCL Business

Transdel set to partner Ketotransdel

Marina Biotech and University of Helsinki extend collaboration

GE begins study to improve treatment selection in early-stage colon cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...